Please login to the form below

I have forgotten my password

Algeta

This page shows the latest Algeta news and features for those working in and with pharma, biotech and healthcare.

Relay Therapeutics strengthens team

He has held roles for Keryx Biopharmaceutical, Algeta ASA and AVEO Oncology.

Latest news

Bayer CEO Dekkers points to 'outstanding' pharma growth

9bn it paid for the drug's developer Algeta last December.
Bayer buys Chinese consumer care company

Bayer buys Chinese consumer care company. Acquires Dihon Pharmaceutical as Algeta takeover closes. ... year. By the extended deadline of February 26 the company had agreements to acquire a little over 97 per cent of Algeta's stock.
Bayer agrees $2.9bn deal for Algeta to get Xofigo control

Bayer agrees $2.9bn deal for Algeta to get Xofigo control. Raises initial offer to buy Norweigan pharma company. ... Bayer has reached an agreement to buy Norwegian pharma company Algeta after raising its offer to around $2.9bn.
Bayer offers $2.4bn to buy Xofigo partner Algeta

Bayer offers $2.4bn to buy Xofigo partner Algeta. Norwegian firm says negotiations still at 'an early stage'. ... One unanswered question is whether Algeta has some other hidden gems in its pipeline.
EU approval for Bayer’s prostate cancer drug

Bayer acquired Xofigo from Norwegian company Algeta in 2009. The deal granted full commercialisation rights in Europe to Bayer while in the US Bayer co-promotes the drug with Algeta.

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

Latest Intelligence

Pharma deals during June 2014

Bayer paid 50m ($68m) upfront payment with further milestones in return for global rights which should complement Xofigo (from the acquisition of Algeta).
Pharma deals during November 2013

Algeta, has been noted as being rather ungenerous, with room for upping the offer. ... Assuming this acquisition goes through, this buys out the previous deal with Algeta under which there was US co-promotion for 50 per cent of in-country profits, plus
Deal Watch table for November 2013

Hyperlipidemia. 2, 600. Algeta / Bayer. Acquisition. Buys out deal for Xofigo radiotherapeutic for.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Targovax appoints chief financial officer

He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey &Company's pharma and healthcare practice.
Targovax appoints Oystein Soug as CEO

He has previously served as chief financial officer for Algeta, a Norwegian oncology biotech that was bought by Bayer in 2014, and spent six years at Orkla, a Norwegian consumer goods
Algeta execs join Targovax

Algeta execs join Targovax. Anna-Kirsti Aksnes and Tina Madsen join the firm. ... Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Associate Scientific Director: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Medical Writers Required - Hertfordshire: Competitive

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer: Salary is DOE

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Medical Writer - Creative and Scientific Projects: DOE

Account Manager- 4 days per week or full-time: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Healthcare PR Senior Account Manager: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Manager: Negotiable

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Account Director or Senior Account Director: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Subscribe to our email news alerts

PMHub

Add my company

infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....